Peptide Amphiphile Nanoparticles Enhance the Immune Response Against a CpG‐Adjuvanted Influenza Antigen
Source abstract
Abstract
Cationic peptide amphiphile nanoparticles are employed for co-delivery of immune modulator CpG and antigen. This results in better targeting to the antigen presenting cells and eliciting strong Th1 response, which is effective against the intracellular pathogens. As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Supramolecular Self-Assembly in Materials · Antimicrobial Peptides and Activities
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Soft Matter Chemistry, Leiden Institute of Chemistry Leiden University P.O. Box 9502 2300 RA Leiden The Netherlands
Division of Drug Delivery Technology, Leiden Academic Centre for Drug Research Leiden University P.O. Box 9502 2300 RA Leiden The Netherlands
Laboratory of Materials and Interface Chemistry Eindhoven University of Technology P.O. Box 513 5600 MB Eindhoven The Netherlands
References (58)
Show source-provided references
1. 10.1021/la200800e10.1021/la200800e ↗
2. 10.1002/bip.2132810.1002/bip.21328 ↗
3. 10.1177/088391151246722210.1177/0883911512467222 ↗
4. 10.1039/B212638A10.1039/B212638A ↗
5. 10.1038/nbt87410.1038/nbt874 ↗
6. 10.1126/science.106318710.1126/science.1063187 ↗
7. 10.1073/pnas.07269999910.1073/pnas.072699999 ↗
8. 10.1039/B906701A10.1039/B906701A ↗
9. 10.1021/ja065479v10.1021/ja065479v ↗
10. 10.1002/anie.20080449310.1002/anie.200804493 ↗
11. 10.1021/ja00142a01910.1021/ja00142a019 ↗
12. 10.1021/bm034058s10.1021/bm034058s ↗
13. 10.1021/mz300258m10.1021/mz300258m ↗
14. 10.1021/ja800254w10.1021/ja800254w ↗
15. 10.1021/ja803026j10.1021/ja803026j ↗
16. 10.1140/epje/e2003-00006-110.1140/epje/e2003-00006-1 ↗
17. 10.1002/marc.20100060310.1002/marc.201000603 ↗
18. 10.1002/mabi.20120000210.1002/mabi.201200002 ↗
19. 10.1002/pola.2052710.1002/pola.20527 ↗
20. 10.1002/mabi.20090005710.1002/mabi.200900057 ↗
21. 10.1126/science.280.5368.142710.1126/science.280.5368.1427 ↗
22. 10.1002/1521-3773(20021115)41:22<4239::AID-ANIE4239>3.0.CO;2-E10.1002/1521-3773(20021115)41:22<4239::AID-ANIE4239>3.0.CO;2-E ↗
23. 10.1021/ma034124i10.1021/ma034124i ↗
24. 10.1002/mabi.20030007910.1002/mabi.200300079 ↗
25. 10.1039/B403203A10.1039/B403203A ↗
26. 10.1021/ma048553810.1021/ma0485538 ↗
27. 10.1002/1521-3773(20020415)41:8<1339::AID-ANIE1339>3.0.CO;2-N10.1002/1521-3773(20020415)41:8<1339::AID-ANIE1339>3.0.CO;2-N ↗
28. 10.1021/ma101251x10.1021/ma101251x ↗
29. 10.1038/nnano.2009.15310.1038/nnano.2009.153 ↗
30. 10.1016/j.actbio.2009.07.03110.1016/j.actbio.2009.07.031 ↗
31. 10.1021/bm101036f10.1021/bm101036f ↗
32. 10.1021/nl048489810.1021/nl0484898 ↗
33. 10.1007/978-1-61779-052-2_1710.1007/978-1-61779-052-2_17 ↗
34. 10.1038/417424a10.1038/417424a ↗
35. 10.1021/bm034249v10.1021/bm034249v ↗
36. 10.1002/adma.20120020910.1002/adma.201200209 ↗
37. 10.1073/pnas.091212410710.1073/pnas.0912124107 ↗
38. 10.1002/adhm.20120043510.1002/adhm.201200435 ↗
39. 10.1021/la300335510.1021/la3003355 ↗
40. 10.1021/ja800254w10.1021/ja800254w ↗
41. 10.1021/ja909540a10.1021/ja909540a ↗
42. 10.1002/med.1005610.1002/med.10056 ↗
43. 10.1039/c0cp02959a10.1039/c0cp02959a ↗
44. 10.2217/17435889.3.3.35710.2217/17435889.3.3.357 ↗
45. 10.1016/j.addr.2007.10.00810.1016/j.addr.2007.10.008 ↗
46. 10.1586/14760584.6.5.79710.1586/14760584.6.5.797 ↗
47. 10.1007/978-1-60761-919-2_3110.1007/978-1-60761-919-2_31 ↗
48. 10.1021/bc060126710.1021/bc0601267 ↗
49. 10.1016/j.antiviral.2006.03.01010.1016/j.antiviral.2006.03.010 ↗
50. 10.1016/j.jconrel.2010.06.00910.1016/j.jconrel.2010.06.009 ↗
51. 10.1016/j.jconrel.2011.02.00710.1016/j.jconrel.2011.02.007 ↗
52. 10.1099/vir.0.19029-010.1099/vir.0.19029-0 ↗
53. 10.1080/0883018060074305710.1080/08830180600743057 ↗
54. 10.1021/bm100176310.1021/bm1001763 ↗
55. 10.1039/c0py00172d10.1039/c0py00172d ↗
56. 10.1039/c1py00010a10.1039/c1py00010a ↗
57. 10.1016/j.vaccine.2008.01.03010.1016/j.vaccine.2008.01.030 ↗
58. 10.1016/j.vaccine.2010.11.06110.1016/j.vaccine.2010.11.061 ↗